Medical weight loss is obesity care led by a licensed prescriber, often including FDA-approved GLP-1 drugs and ongoing monitoring.
The numbers in Detroit
CDC PLACES estimates that 45.6% of Detroit adults had obesity in 2023 and 19.2% had diagnosed diabetes, both higher than Wayne County as a whole (37.4% and 14.3%) [1] [2]. Detroit's median household income was $39,938 in 2020 to 2024, the lowest of the cities in one of our research sets [6]. The city had 649,095 residents in mid-2025 [6].
Put together, that means many Detroiters who meet the label criteria for a weight drug cannot easily pay cash for one. A year of Wegovy pens at $349 a month is $4,188 [4], more than 10% of the median household income.
Sponsored placement: open.
One local practice can be featured here. This is a paid, labeled placement and never an endorsement.
Feature your practice in Detroit, from $300 a month.
The listing is a paid ad and is marked that way. We do not recommend sponsors.
Michigan Medicaid's narrow coverage
A Michigan Department of Health and Human Services letter dated December 8, 2025 limits weight-loss GLP-1 coverage, effective January 1, 2026, to members with morbid obesity who have failed all other interventions, including preferred anti-obesity drugs, in order to avoid bariatric surgery. Coverage for other uses, such as diabetes, did not change [3]. With 19.2% of Detroit adults living with diagnosed diabetes [1], the diabetes rules may matter more than the obesity rules for many people; Ozempic and Mounjaro are diabetes drugs [7] [8].
Lowest cash prices first
| Medicine | Who sells it | Monthly cost | Ref |
|---|---|---|---|
| Wegovy tablet | NovoCare | $149 at 1.5 mg; $199 at 4 mg; $299 at 9 or 25 mg | [4] |
| Foundayo tablet | LillyDirect | $149 to $299, set by strength | [9] |
| Wegovy pen, first two 0.25 and 0.5 mg boxes | NovoCare, new buyers | $199 each, offer ends Dec 31, 2026 | [4] |
| Wegovy pen, 0.25 to 2.4 mg | NovoCare | $349 | [4] |
| Zepbound vial or KwikPen | LillyDirect | $299 to $449; late refills cost more | [5] |
For people searching for semaglutide in Detroit, the 1.5 mg Wegovy pill at $149 is the lowest brand starting price [4], but maintenance doses of 9 or 25 mg cost $299. Lilly's Foundayo pill has the same $149 to $299 spread [9]. See Foundayo vs Wegovy pill and semaglutide cost.
Where Detroiters get care
Large systems in the city include Henry Ford Health and the Detroit Medical Center. We did not find a published weight program price for either, so ask their primary care or endocrinology offices. Another lower-cost path for routine visits is direct primary care: Plum Health DPC in Detroit lists $95 a month for one person and posts cash prices for labs and medicines separately, and does not bill insurance [10]. A DPC doctor can prescribe, though the GLP-1 drug cost is still separate.
Check Michigan physicians with the Michigan Board of Medicine [11]. Compounded semaglutide and tirzepatide are not FDA-approved, and FDA does not review them for safety, effectiveness or quality [12]. Our FDA warning letter tracker and clinic checklist help you screen sellers.
Medicare in Detroit
Roughly 15.1% of Detroiters are 65 or older [6]. If they hold Part D coverage and meet the BMI rules, Medicare's temporary GLP-1 Bridge sets the monthly copay at $50 for Wegovy, Foundayo or a Zepbound KwikPen, ending December 31, 2027 [13] [14]. Other Great Lakes guides: Cleveland, Columbus, Chicago. Start at the weight loss hub.
Important with diabetes
With nearly one Detroit adult in five diagnosed with diabetes [1], many readers already use insulin or a sulfonylurea; a GLP-1 on top raises the chance of a low, and the prescriber may cut the other dose. Stomach pain that is severe and does not ease can be pancreatitis. Anyone with medullary thyroid carcinoma or MEN 2 in their own or family history should not take these drugs. Report vision changes if you have diabetic eye disease [15] [16]. Trouble breathing or a severe allergic reaction: call 911.
Questions people ask
Does Michigan Medicaid cover weight loss drugs?
Only in narrow cases. Since January 1, 2026, Michigan Medicaid covers weight-loss GLP-1s only for members with morbid obesity who have failed all other interventions, to avoid bariatric surgery. Other uses such as diabetes are unchanged [3].
What is the obesity rate in Detroit?
What is the cheapest semaglutide in Detroit?
The 1.5 mg Wegovy pill at $149 a month through NovoCare self-pay, checked Oct 17, 2026. Higher doses cost $199 to $299 [4].
Is there a low-cost primary care option in Detroit?
Plum Health DPC lists $95 a month for one person, $180 for a member plus spouse or child, and $270 for a family, seen Oct 17, 2026. Labs and medicines are priced separately [10].
How do I check a Detroit doctor's license?
Use the Michigan Board of Medicine through LARA [11].
How much weight did people lose on tirzepatide?
In SURMOUNT-1, adults without diabetes on tirzepatide lost an average of 15.0% to 20.9% of body weight at 72 weeks depending on dose, versus 3.1% on placebo [17].
Sources
17 cited
- PLACES place data: Detroit, MI. CDC PLACES (2025 release, BRFSS 2023), 2023 data, 2025 release.
- PLACES county data: Wayne County, MI. CDC PLACES (2025 release, BRFSS 2023), 2023 data, 2025 release.
- MDHHS Numbered Letter L 25-73 (Pharmacy). Michigan Department of Health and Human Services, Dec 8, 2025.
- Wegovy self-pay offer. Novo Nordisk (NovoCare Pharmacy), accessed 2026-10-17.
- Zepbound self-pay pricing. Eli Lilly and Company (LillyDirect), accessed 2026-10-17.
- QuickFacts: Detroit city, Michigan. U.S. Census Bureau, QuickFacts, V2025; ACS 2020-2024.
- Ozempic label. DailyMed, NLM, May 2026.
- Mounjaro label. DailyMed, NLM, Aug 2026.
- Foundayo self-pay pricing. Eli Lilly and Company (LillyDirect), accessed 2026-10-17.
- Pricing. Plum Health DPC, seen 2026-10-17.
- Michigan Board of Medicine. Michigan LARA, accessed 2026-10-17.
- FDA's concerns with unapproved GLP-1 drugs used for weight loss. US Food and Drug Administration, Oct 1, 2026.
- Weight loss drugs coverage. Medicare.gov (CMS), accessed 2026-10-17.
- Medicare GLP-1 Bridge: information for pharmacies. Centers for Medicare & Medicaid Services, accessed 2026-10-17.
- Wegovy label. DailyMed, NLM, Jun 2026.
- Zepbound prescribing information. US FDA (accessdata.fda.gov), Apr 2026.
- Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine (PubMed), Jun 4, 2022.
This page is general information, not medical advice. Talk with a licensed clinician about your own care.